{"id":"W4383683847","doi":"10.58931/cibdt.2023.117","title":"Therapeutic drug monitoring of biologics in inflammatory bowel disease","year":2023,"lang":"en","type":"article","venue":"Canadian IBD Today","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Therapeutic drug monitoring; Medicine; Vedolizumab; Inflammatory bowel disease; Ulcerative colitis; Monoclonal antibody; Drug; Infliximab; Crohn's disease; Biosimilar; Certolizumab pegol; Pharmacokinetics; Disease; Immunology; Pharmacology; Tumor necrosis factor alpha; Intensive care medicine; Internal medicine; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003680042,0.0001103995,0.0001635187,0.000282979,0.00006289253,0.000007175186,0.0001938276,0.0001664235,0.000228523],"category_scores_gemma":[0.0001154167,0.00009277785,0.00006784186,0.0002938511,0.0001801128,0.00002785594,0.000031136,0.0002028133,0.0001320442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007588736,"about_ca_system_score_gemma":0.0002335044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004000253,"about_ca_topic_score_gemma":0.006059301,"domain_scores_codex":[0.9990044,0.0001591527,0.000214012,0.0001906318,0.00002107197,0.0004107781],"domain_scores_gemma":[0.9994655,0.0001348321,0.0000396544,0.0002148254,0.00002777516,0.0001173795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003870554,0.00002098677,0.9647421,0.00004279785,0.00006696634,0.00007750032,0.0002441394,0.00001328504,0.01824102,0.002668985,0.002985277,0.01085824],"study_design_scores_gemma":[0.0002947538,0.0000221449,0.9510816,0.00005256982,0.00002012406,0.000001293763,0.000243444,0.00001733227,0.007869832,0.001557061,0.03867653,0.0001633065],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917935,0.003574318,0.000004087605,0.002230368,0.0009952212,0.0001708257,0.00009437769,0.00005180443,0.001085461],"genre_scores_gemma":[0.9973614,0.0001565334,0.0000439924,0.0002513602,0.00003239511,0.00001065607,0.00001585902,0.000009856744,0.002117979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03569125,"threshold_uncertainty_score":0.6047212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02555785000156629,"score_gpt":0.2733540377454834,"score_spread":0.2477961877439172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}